Figure 51

![Figure 51: Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy." />
  <figcaption>Figure 51. Structural overview of the CB2 cannabinoid receptor, which is primarily expressed in immune cells and microglia. CB2 activation by phytocannabinoids may modulate neuroinflammation associated with epilepsy.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>